NCT02528305

Brief Summary

This pilot study aims to investigate whether 6 weeks of twice weekly High-intensity Interval Training (HIT) results in improvements in disease-specific measures, feelings of general well-being, physical fitness and cognitive function in patients with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 19, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

May 4, 2018

Completed
Last Updated

May 4, 2018

Status Verified

May 1, 2018

Enrollment Period

8 months

First QC Date

August 10, 2015

Results QC Date

December 5, 2016

Last Update Submit

May 3, 2018

Conditions

Keywords

High-intensity Interval Training

Outcome Measures

Primary Outcomes (13)

  • Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)

    calculation of insulin resistance via formula: fasting insulin (mIU/L) x fasting glucose (mg/dL)/405 normal insulin resistance -HOMA score \<3 moderate insulin resistance -HOMA score 3-5 severe insulin resistance -HOMA score \>5 Assessed at baseline, after 6 week control period and within 1 week of completing 6 weeks HIT

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Oral Glucose Tolerance Test

    measurement of capillary samples for glucose at time 0, followed by every 20 minutes for 2 hours following ingestion of 75g glucose. Results graphed against time, then area under the curve calculated for each of the 3 assessments.

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • AST: ALT Ratio

    ratio of liver enzymes aspartate aminotransferase (AST) to alanine aminotransferase (ALT). used as a diagnostic aid e.g. AST:ALT of more than 2:1 is characteristic of alcoholic liver disease whereas fatty steatosis and many other causes of liver disease, ratio is less than or equal to 1. Ratio may rise as fibrosis and cirrhosis develop in viral hepatitis.

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • FIB-4

    calculated from AST, ALT, platelets and participant's age and used to estimate amount of fibrosis in liver. Fib-4 score of \<1.45 has negative predictive value of 90% for advanced fibrosis.

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Body Fat Mass Estimated Via Bioimpedance

    total body fat and trunk fat estimated via bioimpedance measured after overnight fast, expressed as percentage

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Blood Pressure

    taken with participant supine, measured on left arm

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • General Well-being as Assessed by SF-36 Questionnaire

    Assessment of: physical functioning, social functioning, mental health, pain, change in health, physical role limitation, mental role limitation, energy and vitality, health perception over preceding 4 weeks (other than change in health, which is a comparison to health the preceding year), expressed as a transformed score range 0-100, with a higher score indicating better function/freedom from pain etc

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Short-term Memory Recall

    testing of verbal word presentation-immediate recall of 10 words (60 seconds for recall) Maximum =10, minimum =0

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Estimated VO2 Max

    VO2 max estimated via submaximal exercise test-submaximal treadmill walking test Calculated via formula: VO2max= 15.1+21.8 x speed (miles per hour) - 0.327 x heart rate (beats per minute) - 0.263 x speed x age (years) + 0.00504 x heart rate x age + 5.98 x gender (0=female, 1=male)

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Physical Function-"Get up and go" Test

    participant will be timed standing up from chair unaided,walking 30m, turning round and returning to a seated position on the chair, the average time of 3 attempts will be recorded.

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Ankle Brachial Pressure Index (ABPI)

    ratio of blood pressure in left arm and right ankle

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Long-term Memory Recall

    testing of verbal word presentation-delayed recall of 10 words 10 minutes after words initially presented (within 60 seconds). Maximum= 10 words, minimum = no words

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

  • Executive Function (Verbal Fluency Test)

    written verbal fluency test: participant asked to write down as many English words as possible within 60 seconds, starting with a particular letter of the alphabet, excluding proper nouns or plurals. Baseline assessment-letter A Post Control assessment -letter S After HIT assessment -letter F

    Baseline, Follow up at 6 Weeks and following HIT intervention at 12 Weeks

Study Arms (1)

High-intensity Interval Training (HIT)

EXPERIMENTAL

6 week control period with no intervention then 6 weeks of twice weekly HIT

Other: High-intensity Interval Training

Interventions

2 minute warm-up at 50rpm, then increase to 100rpm. Weight added to bike (7% body weight for men 6% body weight for women). Continue effort for 6 seconds, then passive rest for at least 1 minute. Total 5 sprints in sessions 1-3, 6 sprints in session4, 7 sprints in sessions 5\&6, 8 sprints in sessions 7\&8, 9 sprints in sessions 9\&10 and 10 sprints in sessions 11\&12.

Also known as: Exercise
High-intensity Interval Training (HIT)

Eligibility Criteria

Age20 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • clinical diagnosis of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis
  • attending a specialist liver clinic at Ninewells Hospital, Dundee

You may not qualify if:

  • unstable cardiovascular disease
  • uncontrolled arrhythmias
  • structural cardiac abnormalities
  • uncontrolled diabetes
  • other uncontrolled metabolic abnormalities
  • severe orthopaedic condition that would prohibit exercise
  • severe pulmonary condition that would prohibit exercise
  • any other poorly controlled medical condition.
  • resting systolic blood pressure above 160 mm Hg
  • resting diastolic blood pressure above 90 mm Hg
  • symptomatic postural drop in blood pressure greater than 20 mm Hg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Abertay University

Dundee, DD1 1HG, United Kingdom

Location

Ninewells Hospital

Dundee, DD1 9SY, United Kingdom

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

High-Intensity Interval TrainingExercise

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr Niels Vollaard
Organization
University of Striling

Study Officials

  • Niels BJ Vollaard, PhD

    University of Bath

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No Masking, this was not possible with this study design.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Human and Applied Physiology

Study Record Dates

First Submitted

August 10, 2015

First Posted

August 19, 2015

Study Start

October 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

May 4, 2018

Results First Posted

May 4, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

There is no reason to share the IPD.

Locations